European Respiratory Society (ERS) Clinical Training Fellowships offer early career clinicians the chance to train at an institution outside of their home country for between 1–6 months. The programme aims to enable fellows to learn skills or procedures that are not available at their home institution, supporting the exchange of knowledge and best practices across institutes. This programme is not for research projects. For research projects, please consider exploring the Short-Term Research Fellowships or Long-Term Research Fellowships programmes instead.
Applications for the ERS Clinical Training Fellowship are currently open. For information on calls, please refer to the information below.
Call opening:
1 August, 2026
Application deadline:
1 October, 2026
Notification of application decision:
Mid-February, 2027
Selecting a host institution
In the quest for potential training institutions, the Web Host Registry proved invaluable for ERS fellowship applicants facilitating the identification of potential host institutions. However, please note that the Web Host Registry, initially designed for RESPIRE4, might not perfectly align with the requirements of the Clinical Training Fellowship programme. It is imperative to understand that the responsibility for identifying the most suitable institution and supervisor for the application rests entirely with the applicant. In all instances, the choice of the host institution remains the candidate’s prerogative.
This is the highest-priority factor.
Competitive projects should clearly address:
ERS explicitly lists relevance of the topic to respiratory research as a scored criterion.
ERS evaluates the potential impact of the proposed research, including:
Therefore, a strong proposal should clearly explain why the research matters and how successful results could improve respiratory health.
Innovation is an explicit ERS scoring criterion.
Competitive proposals should demonstrate:
A proposal should make clear what is genuinely new rather than simply applying established methods to a familiar question.
ERS specifically evaluates:
A strong application therefore needs a technically convincing methodology and should anticipate potential problems rather than presenting an overly optimistic plan.
The applicant accounts for 40% of the fellowship assessment, making this nearly as important as the research project itself.
ERS considers:
This means the application should present a coherent trajectory showing that the applicant is ready to undertake the proposed work.
ERS fellowships are designed not merely to fund a research project but to develop the next generation of respiratory researchers and clinicians.
A competitive career plan should show:
ERS explicitly scores the quality and feasibility of the career-development plan.
For research fellowships, the host environment contributes 10% of the overall evaluation.
Important factors include:
The Long-Term Research Fellowship specifically enables researchers to work at institutions outside their home country to gain research techniques and expertise unavailable at their home institution.
ERS places significant emphasis on mobility and international collaboration.
Strong applications demonstrate how the fellowship will:
ERS specifically considers the potential for the fellowship to create new international collaborations.
The research plan should address:
ERS explicitly includes ethical processes and a dissemination and outreach plan among its research-project criteria.
ERS has several different funding mechanisms, so applicants should select the programme that matches their career stage and research objective.
For example:
The current ERS portfolio explicitly differentiates these programmes by duration, applicant profile, mobility, and purpose.
a. CTF October 2026: The application deadline is Thursday, 1 October 2026 at 23:59 pm CEST. ERS will notify successful applicants mid-February 2027. CTF can start from 1 March 2027. CTF must begin no later than 29 February 2028. If the fellowship is not started within this timeframe, ERS maintains the right to revoke the fellowship.
b. CTF duration is between 1 and 6 months maximum.
c. Between the notification date and the start of the CTF, successful applicants should complete travel, visa, passport, housing formalities, insurances, etc. To achieve this, they should engage with their host and home institutions and related authorities ahead of time. Failure to fulfill these requirements within the specified timeframe may result in the cancellation of the fellowship.
d. The fellowship is to be carried out on a full-time basis (100%), requiring the fellowship recipient complete dedication to the clinical training. The fellowship cannot be split into separate periods. The fellowship requires physical presence at the host institution. Working from home country is forbidden.
e. Should applicants be potentially interested in working part-time for family or personal reasons, this will need to be requested upfront and agreed with the host institution and ERS. If approved, all the allowances will be calculated pro-rata (30-day month). Kindly note that it may not always be feasible to have such arrangements and applicants must ensure that by working part-time they will be eligible for a visa for the duration of their fellowship in the selected host country.
Academic qualifications
a. Applicants should be actively engaged or must have experience in the respiratory field.
b. Applicants must be qualified clinicians or healthcare professionals working in respiratory health/medicine (nurses, physiotherapists, respiratory function technologists, allied respiratory professionals, etc.). At a minimum, applicants should hold a MD, MSc or equivalent degree at the time of application.
c. Applicants should have adequate fluency in the language spoken at the host institution.
Sponsor Institute/Organizations: European Respiratory Society
Sponsor Type: Corporate/Non-Profit
Address: 4 Avenue Ste-Luce CH1003
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Oct 01, 2026
Oct 01, 2026
$3,461
Varies
Affiliation: European Respiratory Society
Address: 4 Avenue Ste-Luce CH1003
Website URL: https://www.ersnet.org/education-and-professional-development/clinical-training-fellowships/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.